M&A Deal Summary

Avista Capital Partners Acquires UBC

On November 27, 2017, private equity firm Avista Capital Partners acquired life science company UBC from Express Scripts Holding

Acquisition Highlights
  • This is Avista Capital Partners’ 8th transaction in the Life Science sector.
  • This is Avista Capital Partners’ 31st transaction in the United States.
  • This is Avista Capital Partners’ 3rd transaction in Pennsylvania.

M&A Deal Summary
Date 2017-11-27
Target UBC
Sector Life Science
Buyer(s) Avista Capital Partners
Sellers(s) Express Scripts Holding
Deal Type Divestiture

Target

UBC

Blue Bell, Pennsylvania, United States
website
UBC engages in the biopharmaceutical market which provides integrated clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. UBC was founded in 2003 and is based in Blue Bell, Pennsylvania.

Search 192,349 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Avista Capital Partners

New York, New York, United States

website

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 38 of 53
Sector (Life Science) 8 of 13
Type (Divestiture) 6 of 8
State (Pennsylvania) 3 of 3
Country (United States) 31 of 43
Year (2017) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-12 OptiNose

Yardley, Pennsylvania, United States

OptiNose is a specialty pharmaceutical company focused on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. OptiNose was founded in 2000 and is based in Yardley, Pennsylvania.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-08 Zest Dental Solutions

Carlsbad, California, United States

Zest Dental Solutions is a provider of dental solutions across a continuum of patient care. Zest is widely known as the global leader in reliable, innovative restorative solutions for the treatment of edentulous patients. In recent years, Zest has strengthened its offering by expanding the breadth of its product portfolio, with acquisitions of restorative consumables and small equipment products. Zest Dental Solutions is headquartered in Carlsbad, California with operations in Anaheim and Escondido, California.

Sell -

Seller(S) 1

SELLER

Express Scripts Holding

St. Louis, Missouri, United States

website

Category Company
Founded 1986
Sector Healthcare Services
Employees25,900
Revenue 100.1B USD (2017)
DESCRIPTION

Express Scripts Holding Co. is a provider of integrated pharmacy-benefit management services. Services include network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. Express Scripts Holding Co. was formed in 1986 and is based in St. Louis, Missouri.

DEAL STATS #
Overall 4 of 4
Sector (Life Science) 1 of 1
Type (Divestiture) 4 of 4
State (Pennsylvania) 1 of 1
Country (United States) 3 of 3
Year (2017) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-10 EviCore Healthcare

Bluffton, South Carolina, United States

eviCore offers proven, diversified medical benefits management solutions that help clients reduce costs while increasing quality of care for their members. The company provides these solutions to managed care organizations and risk-bearing provider organizations serving commercial, Medicare, and Medicaid populations. Powered by a team of specialized medical professional resources, extensive evidence-based guidelines, and advanced technologies, eviCore supports clients by ensuring the right evidence-based care is delivered at the right time to the right patient at the right site of care. Flexible medical benefits management solutions are offered in: Radiology; Cardiology; Musculoskeletal; Medical Oncology; Radiation Therapy; Specialty Drug Management; Sleep; Lab Management; and Post-Acute Care. eviCore is proud to help 100 million members receive higher quality, lower cost healthcare.

Buy $3.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-02 Verity Solutions Group

Kirkland, Washington, United States

Verity Solutions is a provider of software and services developed for administration of the federal 340B drug pricing program. The Company simplifies the complex process of maintaining 340B PROGRAM compliance resulting in critical 340B cost savings for our customers.

Buy -
Mergr

Product

Company

Legal